导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -12.59% | 870/1050 |
| 近一周 | -2.11% | 456/1104 |
| 近一月 | -4.15% | 520/1102 |
| 近一季 | -1.28% | 299/1092 |
| 近半年 | -10.43% | 775/1070 |
| 近一年 | -16.64% | 840/1018 |
| 近两年 | -6.16% | 909/926 |
| 近三年 | -24.97% | 794/834 |
| 成立以来 | 98.28% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-3.33% 736/1070 |
-13.68% 995/1101 |
- - |
- - |
| 2025 | -6.28% 951/1065 |
-4.95% 986/1014 |
1.44% 556/1038 |
-2.50% 1021/1050 |
-0.30% 473/1065 |
| 2024 | -7.64% 739/1011 |
-3.74% 523/960 |
-1.64% 414/983 |
5.40% 869/991 |
-7.45% 800/1011 |
| 2023 | -1.30% 122/952 |
16.04% 47/880 |
-1.56% 274/895 |
-10.08% 590/915 |
-3.91% 400/952 |
| 2022 | 4.02% 10/867 |
-4.02% 23/773 |
-0.56% 705/806 |
-11.68% 365/845 |
23.38% 7/867 |
| 2021 | 36.41% 43/740 |
-0.63% 180/580 |
17.30% 201/659 |
-4.45% 330/704 |
22.48% 5/740 |
| 2020 | 14.93% 394/554 |
-1.64% 204/419 |
18.17% 314/466 |
2.37% 398/517 |
-3.41% 507/554 |
| 2019 | 36.30% 250/410 |
27.41% 663/3053 |
2.82% 322/3201 |
0.08% 329/390 |
3.96% 363/410 |
| 2018 | - - |
- - |
-0.76% 912/2983 |
7.72% 16/2970 |
0.08% 462/2975 |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8316 | 54.00% |
| 招商前沿医疗保健股票C | 0.7978 | 53.69% |
| 招商医药健康产业股票 | 2.5730 | 48.73% |
| 嘉实医疗保健股票 | 2.5780 | 39.05% |
| 广发医药精选股票A | 1.3132 | 38.48% |
| 广发医药精选股票C | 1.2923 | 38.32% |
| 前海开源公共卫生股票A | 0.4690 | 37.42% |
| 前海开源公共卫生股票C | 0.4590 | 37.30% |
| 交银医药创新股票C | 3.0594 | 35.86% |
| 交银医药创新股票A | 2.8810 | 32.85% |
| 前海开源中药股票C VS. 东吴新产业精选股票A(580008) |